Delivery Order SPE2DR25D6044-SPE2DR26FYA9Y
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Verapamil SR 180 mg capsules (100 count) on December 23, 2025, with a ceiling value of $1,565.71 and completion date of December 24, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,565.47 to AmerisourceBergen Drug Corp for the supply of Verapamil SR 120 mg capsules (100-count units) on January 13, 2026. This is a firm fixed-price, non-set-aside contract with a completion date of January 14, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Verapamil ER PM 300 mg capsules (100-count units) on January 22, 2026, with a ceiling value of $1,731.61. This firm fixed-price delivery order, which has an ultimate completion date of January 23, 2026, represents a task order under a larger indefinite delivery contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on January 20, 2026, for the supply of Verapamil SR 240 mg capsules (100 count) with a contract value of $3,683.36. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 21, 2026. AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,805.92 to supply Verapamil SR 360 mg capsules (100-count units) with an ultimate completion date of November 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a straightforward pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,399.45 to AmerisourceBergen Drug Corp for Verapamil SR 360 mg capsules (100 count) on September 2, 2025, with completion scheduled for September 3, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Verapamil SR is a calcium channel blocker commonly used to treat hypertension and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Verapamil SR 180 mg capsules (100-count units) with a ceiling value of $2,049.48. This contract represents a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Verapamil SR 360 mg capsules (100 count) on January 5, 2026, with a ceiling value of $1,145.13 and completion date of January 6, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Verapamil ER PM 300 mg capsules (100-count units) valued at $1,460.92, with an ultimate completion date of September 4, 2025. This non-set-aside, firm fixed-price contract represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Verapamil SR 360 mg capsules (100-count packaging) under a firm fixed-price contract with a ceiling value of $1,445.70. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, and represents a non-competitive, non-set-aside contract. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DR25D6044Indefinite Delivery Contract
- SPE2DR25D6044-SPE2DR26FYA9YDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,720.01 to AmerisourceBergen Drug Corp for the supply of Verapamil SR 240 mg capsules (100-count units) on January 29, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of January 30, 2026, was competitively awarded without set-aside designation. The products will be delivered to the Conshohocken, Pennsylvania location, which serves as the awardee's corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor specializing in supplying medications and medical supplies to federal healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Verapamil SR, a calcium channel blocker used in cardiovascular treatment, represents one of many pharmaceutical products the company provides through this prime vendor agreement to support the Defense Health Agency and other federal medical institutions. The contract vehicle demonstrates AmerisourceBergen's established capability to efficiently fulfill critical pharmaceutical requirements for military treatment facilities and government healthcare systems on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 1/28/26 |